Long-term outcome in patients with acromegaly: Analysis of 1344 patients from the German Acromegaly Register

European Journal of Endocrinology

Volumn 168, Issue 1, 2013, Pages 39-47

  Schöfl, Christof ^a   Franz, Holger ^b   Grussendorf, Martin ^c   Honegger, Jürgen ^d   Jaursch Hancke, Cornelia ^e   Mayr, Bernhard ^a   Schopohl, Jochen ^f   Badenhoop, K ^g   Bender, G ^g   Berg, C ^g   Biering, H ^g   Bogner, U ^g   Bornstein, S R ^g   Cissewski, K ^g   Demtroder F ^g   Droste, M ^g   Engelbach, M ^g   Feldkamp, J ^g   Finke, R ^g   Friesenhahn Ochs, B ^g   Gain, T ^g   Gallwitz, B ^g   Gerhardt, A ^g   Grussendorf M ^g   Haaser, D ^g   Hampel, R ^g   Hering, S ^g   Honegger, J ^g   Jacobeit, J ^g   Janssen O ^g   Jaursch Hancke, C ^g   Jungmann, E ^g   Kajdan, U ^g   Kann, P ^g   Kastrinaki, A ^g   Klein, H ^g   Klingmuller D ^g   Kornely, E ^g   Lehnert, H ^g   Lerch, M M ^g   Loessner, C ^g   Metzner, C ^g   Meuser, J ^g   Meyer, A ^g   Monig H ^g   Muller A ^g   Pichl, J ^g   Plockinger U ^g   Ploner, O ^g   Quinkler, M ^g   Reschke, K ^g   Ritter, M ^g   Schaffler A ^g   Schofl C ^g   Schopohl, J ^g   Seufert, J ^g   Sievers, C ^g   Siggelkow, H ^g   Streetz van der Werf, C ^g   Strasburger, C J ^g   Tonjes A ^g   Willenberg, H ^g   Zimmermann, A ^g   Zumbusch, K ^g   more..

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Lohmann and Birkner Health Care Consulting GmbH   (Germany)

^c Center of Endocrinology and Diabetes   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; GROWTH HORMONE; OCTREOTIDE; PEGVISOMANT; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOTHERAPY; RETROSPECTIVE STUDY; SCHOOL CHILD; TRANSSPHENOIDAL SURGERY;

ACROMEGALY; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GERMANY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84871944971     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0602     Document Type: Article

References (45)

1. Melmed S. Medical progress: acromegaly. New England Journal of Medicine 2006 355 2558-2573. (doi:10.1056/NEJMra062453)
2. Ben Shlomo A, Sheppard MC, Stephens JM, Pulgar S & Melmed S. Clinical, quality of life, and economic value of acromegaly disease control. Pituitary 2011 14 284-294. (doi:10.1007/s11102-011-0310-7)
3. Holdaway IM, Bolland MJ & Gamble GD. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. European Journal of Endocrinology 2008 159 89-95. (doi:10.1530/EJE-08-0267)
4. Dekkers OM, Neelis KJ, de Keizer RJ, Voormolen JH, Pereira AM & Romijn JA. Nonfunctioning pituitary macroadenomas: diagnosis, treatment and follow-up. Nederlands Tijdschrift Voor Geneeskunde 2008 152 792-796. (Pubitemid 351529704)
5. Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J et al. Guidelines for acromegaly management: an update. Journal of Clinical Endocrinology and Metabolism 2009 94 1509-1517. (doi:10.1210/jc.2008-2421)
6. Kreutzer J, Vance ML, Lopes MB & Laws ER Jr. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. Journal of Clinical Endocrinology and Metabolism 2001 86 4072-4077. (doi:10.1210/jc.86.9.4072)
7. Nomikos P, Buchfelder M & Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'. European Journal of Endocrinology 2005 152 379-387. (doi:10.1530/eje.1.01863)
8. Lüdecke DK & Abe T. Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations. Neuroendocrinology 2006 83 230-239. (doi:10.1159/000095533)
9. Laws ER. Surgery for acromegaly: evolution of the techniques and outcomes. Reviews in Endocrine & Metabolic Disorders 2008 9 67-70. (doi:10.1007/s11154-007-9064-y)
10. Barrande G, Pittino-Lungo M, Coste J, Ponvert D, Bertagna X, Luton JP & Bertherat J. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. Journal of Clinical Endocrinology and Metabolism 2000 85 3779-3785. (doi:10.1210/jc.85.10. 3779)
11. Minniti G, Jaffrain-Rea ML, Osti M, Esposito V, Santoro A, Solda F, Gargiulo P, Tamburrano G & Enrici RM. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clinical Endocrinology 2005 62 210-216. (doi:10.1111/j.1365-2265.2005.02199.x)
12. Jenkins PJ, Bates P, Carson MN, Stewart PM & Wass JA. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2006 91 1239-1245. (doi:10.1210/jc.2005-1616)
13. Attanasio R, Baldelli R, Pivonello R, Grottoli S, Bocca L, Gasco V, Giusti M, Tamburrano G, Colao A & Cozzi R. Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly. Journal of Clinical Endocrinology and Metabolism 2003 88 5258-5265. (doi:10.1210/jc.2003-030266)
14. Castinetti F, Taieb D, Kuhn JM, Chanson P, Tamura M, Jaquet P, Conte-Devolx B, Regis J, Dufour H & Brue T. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. Journal of Clinical Endocrinology and Metabolism 2005 90 4483-4488. (doi:10.1210/jc.2005-0311)
15. Jezkova J, Marek J, Hana V, Krsek M, Weiss V, Vladyka V, Lisak R, Vymazal J & Pecen L. Gamma knife radiosurgery for acromegaly - long-term experience. Clinical Endocrinology 2006 64 588-595. (doi:10.1111/j.1365-2265. 2006.02513.x)
16. Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). European Journal of Endocrinology 2004 151 439-446. (doi:10.1530/eje.0.1510439)
17. Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM & Bates AS. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 1613-1617. (doi:10.1210/jc.2003-031584)
18. Kauppinen-Mäkelin R, Sane T, Reunanen A, Valimaki MJ, Niskanen L, Markkanen H, Loyttyniemi E, Ebeling T, Jaatinen P, Laine H et al. A nationwide survey of mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2005 90 4081-4086. (doi:10.1210/jc.2004-1381)
19. Reincke M, Petersenn S, Buchfelder M, Gerbert B, Skrobek-Engel G, Franz H, Lohmann R & Quabbe HJ. The German Acromegaly Registry: description of the database and initial results. Experimental and Clinical Endocrinology & Diabetes 2006 114 498-505. (doi:10.1055/s-2006-948313)
20. Bex M, Abs R, T'Sjoen G, Mockel J, Velkeniers B, Muermans K & Maiter D. AcroBel - the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects. European Journal of Endocrinology 2007 157 399-409. (doi:10.1530/EJE-07-0358)
21. Fieffe S, Morange I, Petrossians P, Chanson P, Rohmer V, Cortet C, Borson-Chazot F, Brue T & Delemer B. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. European Journal of Endocrinology 2011 164 877-884. (doi:10.1530/EJE-10-1050)
22. Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavo S et al. Predictors of morbidity and mortality in acromegaly: an Italian survey. European Journal of Endocrinology 2012 167 189-198.
23. Kwon O, Song YD, Kim SY & Lee EJ. Nationwide survey of acromegaly in South Korea. Clinical Endocrinology 2012. In press. (doi:10.1111/cen.12020)
24. Sesmilo G, Gaztambide S, Venegas E, Pico A, Del Pozo C, Blanco C, Torres E, Alvarez-Escola C, Fajardo C, Garcia R et al. Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA). Pituitary 2012. In press. (doi:10.1007/s11102-012-0384-x)
25. Petersenn S, Buchfelder M, Reincke M, Strasburger CM, Franz H, Lohmann R, Quabbe HJ & Plöckinger U. Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register. European Journal of Endocrinology 2008 159 525-532. (doi:10.1530/EJE-08-0498)
26. Petersenn S, Buchfelder M, Gerbert B, Franz H, Quabbe HJ, Schulte HM, Grussendorf M & Reincke M. Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register. Clinical Endocrinology 2009 71 400-405. (doi:10.1111/j.1365-2265.2009.03547.x)
27. Brabant G. Insulin-like growth factor-I: marker for diagnosis of acromegaly and monitoring the efficacy of treatment. European Journal of Endocrinology 2003 148 S15-S20. (doi:10.1530/eje.0.148S015)
28. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K & Melmed S. A consensus on criteria for cure of acromegaly. Journal of Clinical Endocrinology and Metabolism 2010 95 3141-3148. (doi:10.1210/jc.2009-2670)
29. Arafat AM, Möhlig M, Weickert MO, Perschel FH, Purschwitz J, Spranger J, Strasburger CJ, Schöfl C & Pfeiffer AF. Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. Journal of Clinical Endocrinology and Metabolism 2008 93 1254-1262. (doi:10.1210/jc.2007-2084)
30. Bidlingmaier M & Freda PU. Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. Growth Hormone & IGF Research 2010 20 19-25. (doi:10.1016/j.ghir.2009.09. 005)
31. Holdaway IM & Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999 2 29-41. (doi:10.1023/A:1009965803750)
32. Schneider HJ, Sievers C, Saller B, Wittchen HU & Stalla GK. High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clinical Endocrinology 2008 69 432-435. (doi:10.1111/j.1365-2265. 2008.03221.x)
33. Psaras T, Milian M, Hattermann V, Gallwitz B, Freiman T & Honegger J. Aftercare in patients with Cushing's disease and acromegaly: is there room for improvement? Acta Neurochirurgica 2010 152 271-278. (doi:10.1007/s00701-009- 0544-6)
34. Frystyk J, Freda P & Clemmons DR. The current status of IGF-I assays - a 2009 update. Growth Hormone & IGF Research 2010 20 8-18. (doi:10.1016/j.ghir.2009.09.004)
35. Bidlingmaier M. Pitfalls of insulin-like growth factor I assays. Hormone Research 2009 71 (Suppl 1) 30-33. (doi:10.1159/000178034)
36. Alexopoulou O, Bex M, Abs R, T'Sjoen G, Velkeniers B & Maiter D. Divergence between growth hormone and insulin-like growth factor-I concentrations in the follow-up of acromegaly. Journal of Clinical Endocrinology and Metabolism 2008 93 1324-1330. (doi:10.1210/jc.2007-2104)
37. Arafat AM, Müller L, Möhlig M, Mayr B, Kremenevskaya N, Pfeiffer AF, Buchfelder M & Schöfl C. Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibility. Clinical Endocrinology 2011 75 685-691. (doi:10.1111/j.1365-2265.2011.04108.x)
38. Carmichael JD, Bonert VS, Mirocha JM & Melmed S. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2009 94 523-527. (doi:10.1210/jc.2008-1371)
39. Freda PU. Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clinical Endocrinology 2009 71 166-170. (doi:10.1111/j.1365-2265.2009.03556.x)
40. Giustina A, Bronstein MD, Casanueva FF, Chanson P, Ghigo E, Ho KK, Klibanski A, Lamberts S, Trainer P & Melmed S. Current management practices for acromegaly: an international survey. Pituitary 2011 14 125-133. (doi:10.1007/s11102-010-0269-9)
41. Bates PR, Carson MN, Trainer PJ & Wass JA. Wide variation in surgical outcomes for acromegaly in the UK. Clinical Endocrinology 2008 68 136-142. (doi:10.1111/j.1365-2265.2007.03012.x)
42. Erturk E, Tuncel E, Kiyici S, Ersoy C, Duran C & Imamoglu S. Outcome of surgery for acromegaly performed by different surgeons: importance of surgical experience. Pituitary 2005 8 93-97. (doi:10.1007/s11102-005-3280-9)
43. Trainer PJ. ACROSTUDY: the first 5 years. European Journal of Endocrinology 2009 161 (Suppl 1) S19-S24. (doi:10.1530/EJE-09-0322)
44. Davi' MV, Dalle CL, Giustina A, Ferrari M, Frigo A, Lo Cascio V & Francia G. Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. European Journal of Endocrinology 2008 159 533-540. (doi:10.1530/EJE-08-0442)
45. van Thiel SW, Bax JJ, Biermasz NR, Holman ER, Poldermans D, Roelfsema F, Lamb HJ, van der Wall EE, Smit JW, Romijn JA et al. Persistent diastolic dysfunction despite successful long-term octreotide treatment in acromegaly. European Journal of Endocrinology 2005 153 231-238. (doi:10.1530/eje.1.01955)